OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 66 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 4.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $65,000 | -66.7% | 115,435 | +1.6% | 0.00% | -100.0% |
| Q4 2015 | $195,000 | -2.5% | 113,660 | +19.9% | 0.00% | 0.0% |
| Q3 2015 | $200,000 | -57.8% | 94,805 | -1.0% | 0.00% | -50.0% |
| Q2 2015 | $474,000 | -50.6% | 95,776 | -21.9% | 0.00% | -33.3% |
| Q1 2015 | $960,000 | +55.3% | 122,636 | +20.3% | 0.00% | +50.0% |
| Q4 2014 | $618,000 | +50.4% | 101,911 | +5.7% | 0.00% | +100.0% |
| Q3 2014 | $411,000 | -33.7% | 96,436 | -3.9% | 0.00% | -50.0% |
| Q2 2014 | $620,000 | +9.5% | 100,391 | +15.2% | 0.00% | 0.0% |
| Q1 2014 | $566,000 | +15.5% | 87,127 | +0.0% | 0.00% | +100.0% |
| Q4 2013 | $490,000 | -10.1% | 87,087 | -1.8% | 0.00% | -50.0% |
| Q3 2013 | $545,000 | +6.9% | 88,707 | +1.8% | 0.00% | 0.0% |
| Q2 2013 | $510,000 | – | 87,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |